Korean J Fam Pract. 2017; 7(3): 437-441  https://doi.org/10.21215/kjfp.2017.7.3.437
The Relationship between Abdominal Ultrasonographic Finding of the Fatty Liver and Type of Dyslipidemia in Health Check-up Subjects Except Moderate or Severe Obese People
Dong A Lee*, Jae Bin Kim, Min Gou Song, Young Ho Koh, Hee Kwon Yu
Department of Family Medicine, Dongsuwon General Hospital, Suwon, Korea
Dong A Lee
Tel: +82-43-642-4000, Fax: +82-43-644-5599
E-mail: drlda@naver.com
Received: June 7, 2016; Revised: September 27, 2016; Accepted: October 6, 2016; Published online: June 20, 2017.
© Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background: We already know the relationships between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia, but most studies have focused on extremely obese people. At this time, weight loss is the only definite therapy for fatty liver disease. Because the concept of a “obesity paradox” has been gaining prominence, we have attempted to show the relationships between indexes of dyslipidemia and fatty liver disease on abdominal sonography for people with body mass indexs (BMIs) less than 30 kg/m2 and with lowest death rate.
Methods: The subjects were 4,768 patients who underwent BMI evaluations, blood tests, abdomen ultrasonography, and public corporation medical exams at a hospital health clinic in Suwon, Gyeonggi-do between January 2013 and December 2014, and were retrospectively enrolled in the study. They were over 20 years old, and we excluded patients who had viral hepatitis A, B, or C, suspected liver cirrhosis on abdominal sonography, or BMIs >30 kg/m2.
Results: The correlation coefficient of dyslipidemia indexes and NAFLD was calculated, triglyceride 0.359, total cholesterol 0.208, low density lipoprotein cholesterol 0.161. Triglyceride in particular had the strongest correlation.
Conclusion: Because triglyceride had the strongest correlation with NAFLD in non-obese people, we suggest that it may be predictive of increasing obesity and NAFLD among people with BMIs less than 30 kg/m2.
Keywords: Dyslipidemia; Non-Alcoholic Fatty Liver Disease; Paradox of Obesity
  1. Fitzgerald KR. Review of article: prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010 by Katherine M. Flegal, PhD; Margaret D. Carroll, MSPH; Brian K. Kit, MD; Cynthia L. Ogden, PhD (JAMA 2012;307:491-7). J Vasc Nurs 2013; 31: 131-2.
    Pubmed CrossRef
  2. Ministry of Health and Welfare. Korea Centers for Disease Control and Prevention. Korea Health Statistics 2012: Korea National Health and Nutrition Examination Survey (KNHANES V-3). Cheongwon: Korea Centers for Disease Control and Prevention; 2013.
  3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-292.
    Pubmed KoreaMed CrossRef
  4. Committee for the Korean guidelines for the management of dyslipidemia. 2015 Korean guidelines for the management of dyslipidemia: executive summary (English translation). Korean Circ J 2016; 46: 275.
    Pubmed KoreaMed CrossRef
  5. Scherlock DS. Nutritional and metabolic liver disease. In: Sherlock S, Dooley J, editors. Disease of the liver and biliary system. 10th ed. Oxford: Blackwell Science; 1997. p. 427-33.
  6. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
    Pubmed CrossRef
  7. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
    Pubmed CrossRef
  8. Luyckx FH, Desaive C, Thiry A, Dewé W, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222-6.
    Pubmed CrossRef
  9. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-9.
    Pubmed CrossRef
  10. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-7.
    Pubmed CrossRef
  11. Yeon JE. The clinical implication of non-alcoholic fatty liver disease. J Korean Acad Fam Med 2003; 24: 510-5.
  12. Lim S. Epidemiology and candidate genes of non-alcoholic fatty liver disease. J Korean Diabetes 2014; 15: 71-5.
  13. Myers J, Lata K, Chowdhury S, McAuley P, Jain N, Froelicher V. The obesity paradox and weight loss. Am J Med 2011; 124: 924-30.
    Pubmed CrossRef
  14. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories:a systematic review and meta-analysis. JAMA 2013; 309: 71-82.
    Pubmed KoreaMed CrossRef
  15. Kim SG. Treatment of Non-obese NAFLD. Seoul: Korean Association for the Study of the Liver; 2015. p. 120-5.
  16. Danforth E Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 2000; 26: 13.
    Pubmed CrossRef
  17. Krssak M, Falk Petersen K, Dresner A, DiPietro L, Vogel SM, Rothman DL, et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999; 42:113-6.
    Pubmed CrossRef
  18. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev 2008; 29: 777-822.
    Pubmed KoreaMed CrossRef
  19. Park DB. Non-Alcoholic fatty liver disease and metabolic syndrome. J Korean Soc Pediatr Endocrinol 2010; 15: 77-84.

This Article